Preconceptional screening of couples for carriership of cystic fibrosis in the Netherlands: Experts and savings;Preconceptionele screening van paren op dragerschap van cystische fibrose in Nederland: Kosten en besparingen

Nederlands Tijdschrift voor Geneeskunde

Volumn 142, Issue 13, 1998, Pages 706-710

  Verheij, J B G M ^a   Hilderink, H B M ^b   Verzijl, J G ^b   Wildhagen, M F ^b   Habbema, J D F ^b   Ten Kate, L P ^c  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARITHMETIC; ARTICLE; COST CONTROL; CYSTIC FIBROSIS; SCREENING TEST; TREATMENT PLANNING;

ADULT; COST-BENEFIT ANALYSIS; CYSTIC FIBROSIS; DECISION TREES; FEMALE; GENETIC SCREENING; HETEROZYGOTE; HUMANS; MALE; MODELS, STATISTICAL; NETHERLANDS; PARENTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 0032574598     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Kate LP ten. Erfelijkheid en epidemiologie van kystische fibrose (mucoviscidose). Ned Tijdschr Geneeskd 1979;123:1020-7.
2. Vries HG de, Collée JM, Walle HE de, Veldhuizen MH van, Smit Sibinga CT, Scheffer H, et al. Prevalence of delta F508 cystic fibrosis carriers in the Netherlands: logistic regression on sex, age, region of residence and number of offspring. Hum Genet 1997;99:74-9.
3. Rommens JM, Iannuzzi MC, Kerem BS, Drumm ML, Melmer G, Dean M, et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989,245:1059-65.
4. Riordan JR, Rommens JM, Kerem BS, Alon N. Rozmahel R, Grzclczak Z, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245: 1066-73.
5. Kerem BS, Rommens JM, Buchanan JA. Markiewicz D, Cox TK, Chakravarti A, et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989;245:1073-80.
6. CF Genetic Analysis Consortium. URL: http://www.genet.sickkidsonca/cftr.
7. Genetic testing for cystic fibrosis. NIH Consensus Statement 1997: http://odp.od.nih.gov/consensus/statements/cdc/106/106stmt.html.
8. Kate LP ten, Verheij JBGM, Wildhagen MF, Hilderink HB, Kooij L, Verzijl JG, et al. Comparison of single-entry and double-entry two-step couple screening for cystic fibrosis carriers. Hum Hered 1996;46:20-5.
9. Centraal Bureau voor de Statistiek. Geboorte. 1991-1995. Mndstat Bcvolk 1996;12:46-55.
10. Bekker H, Modell M, Denniss G, Silver A, Mathew C, Brobow M, et al. Uptake of cystic fibrosis testing in primary care: supply push or demand pull? BMJ 1993;306-1584-6.
11. Decruyenaere M, Evers-Kiebooms G, Denaycr L, Berghe H van den. Cystic fibrosis: community knowledge and attitudes towards carrier screening and prenatal diagnosis. Clin Genet 1992;41:189-96.
12. Loader S, Caldwell P, Kozyra A, Levenkron JC, Boehm CD, Kazazian jr HH, et al. Cystic fibrosis carrier population screening in the primary care setting. Am J Hum Genet 1996;59:234-47.
13. Witt DR, Schaefer C. Hallam P, Wi S, Blumberg B, Fishbach A, et al. Cystic fibrosis heterozygote screening in 5,161 pregnant women. Am J Hum Genet 1996;58:823-33.
14. Brock DJH. Prenatal screening for cystic fibrosis: 5 years' experience reviewed. Lancet 1996;347:148-50.
15. Brandt NJ, Schwartz M, Skovby F. Orientering om anlaegsbaerer-screening for cystisk fibrose. Ugeskr Laeger 1991;153:1365-8.
16. Hillman AL, Schwartz JS, Pauly MV, Bloom BS, Eisenberg JM, William MK. Economic analysis of health care technology. A report on principles. Ann Intern Med 1995;123:61-70.
17. Koning HJ de. Ineveld BM van. Oortmarssen GJ van, Boer R, Colllette HJA, Verbeek ALM, et al. Kosten en effecten van bevolkingsonderzoek op borstkanker. Eindrapport. Rotterdam: Erasmus Universiteit, 1990.
18. Vries HG de, Collée JM, Veldhuizen MHR van, Achterhof L, Smit Sibinga CT, Scheffer H, et al. Validation of the determination of deltaF508 mutations of the cystic fibrosis gene in over 11000 mouthwashes. Hum Genet 1996;97:334-6.
19. Wildhagen MF, Verheij JBGM, Verzijl JG, Gerritsen J, Bakker W, Hilderink HB, et al. The nonhospital costs of care of patients with CF in the Netherlands: results of a questionnaire. Eur Respir J 1996;9:2215-9.
20. Collée JM, Cobben JM, Kate LP ten. Inventarisatie cystic fibrosis in Nederland. Nederlandse CF-registratie. Groningen: Rijksuniversiteit Groningen, 1993.
21. Wildhagen MF, Verheij JBGM, Verzijl JG, Hilderink HBM, Kooij L, Tijmstra T, et al. Cost of care of patients with cystic fibrosis in the Netherlands in 1990-1. Thorax 1996;51:298-301.
22. Kooij L. Screening op gendragerschap van cystische fibrose: vooren nadelen van verschillende scenario's. Ned Tijdschr Geneeskd 1994;138:818-23.
23. Laar J van de, Kate LP ten. Preconceptionele screening op dragerschap voor cystische fibrose; toetsing aan de Gezondheidsraad-criteria voor genetische screening. Ned Tijdschr Geneeskd 1996; 140.487-91.
24. Wildhagen MF, Hilderink HBM, Verzijl JG, Verheij JBGM, Kooij L, Tijmstra Tj, et al. Costs, effects and savings of screening for CF-gene carriers J Epidemiol Community Health [ter perse].
25. Cox TK, Chakravarti A. Detection of cystic fibrosis gene carriers: comparison of two screening strategies by simulations. Am J Hum Genet 1991;49(Suppl 4):327.
26. Super M, Schwarz MJ, Malone G. Screening for cystic fibrosis carriers [letter]. Lancet 1992;340:490-1.
27. Kaback M, Zippin D, Boyd P, Cantor R Attitudes towards prenatal diagnosis of cystic fibrosis among parents of affected children. In: Lawson D, editor. Cystic fibrosis: horizons. Chichester. Wiley, 1984:15-28.
28. Williamson R. Universal community carrier screening for cystic fibrosis? Nat Genet 1993;3:195-201.